SK282796B6 - Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom - Google Patents

Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom Download PDF

Info

Publication number
SK282796B6
SK282796B6 SK1940-2000A SK19402000A SK282796B6 SK 282796 B6 SK282796 B6 SK 282796B6 SK 19402000 A SK19402000 A SK 19402000A SK 282796 B6 SK282796 B6 SK 282796B6
Authority
SK
Slovakia
Prior art keywords
ment
testosterone
undecanoate
compound
androgen
Prior art date
Application number
SK1940-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK19402000A3 (sk
Inventor
Dirk Leysen
Der Voort Hendrikus Adrianus Antonius Van
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of SK19402000A3 publication Critical patent/SK19402000A3/sk
Publication of SK282796B6 publication Critical patent/SK282796B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK1940-2000A 1998-06-19 1999-06-14 Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom SK282796B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en) 1998-06-19 1999-06-14 Testosterone derivative

Publications (2)

Publication Number Publication Date
SK19402000A3 SK19402000A3 (sk) 2001-07-10
SK282796B6 true SK282796B6 (sk) 2002-12-03

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1940-2000A SK282796B6 (sk) 1998-06-19 1999-06-14 Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom

Country Status (26)

Country Link
US (3) US6437158B1 (de)
EP (1) EP1087986B1 (de)
JP (1) JP2002518514A (de)
KR (1) KR100596649B1 (de)
CN (1) CN1172949C (de)
AT (1) ATE215961T1 (de)
AU (1) AU756739B2 (de)
BR (1) BR9911344A (de)
CA (1) CA2333985C (de)
CZ (1) CZ293319B6 (de)
DE (1) DE69901250T2 (de)
DK (1) DK1087986T3 (de)
ES (1) ES2175989T3 (de)
HK (1) HK1034263A1 (de)
HU (1) HUP0102274A3 (de)
ID (1) ID27260A (de)
IL (1) IL139689A (de)
NO (1) NO316518B1 (de)
NZ (1) NZ508299A (de)
PL (1) PL191285B1 (de)
PT (1) PT1087986E (de)
RU (1) RU2216546C2 (de)
SK (1) SK282796B6 (de)
TR (1) TR200003743T2 (de)
WO (1) WO1999067271A1 (de)
ZA (1) ZA200006813B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (de) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
BR0112791A (pt) * 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (de) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Mehrschirmanzeigevorrichtung und Verfahren für ein digitales Rundfunkempfangsgerät
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
CA2868500C (en) * 2012-04-06 2020-04-21 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
EP3659647B1 (de) 2013-02-11 2024-01-24 Antares Pharma, Inc. Nadelgestützte düseninjektionsvorrichtung mit reduzierter auslöserkraft

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
NO316518B1 (no) 2004-02-02
AU4610199A (en) 2000-01-10
US6437158B1 (en) 2002-08-20
EP1087986B1 (de) 2002-04-10
KR20010052850A (ko) 2001-06-25
ATE215961T1 (de) 2002-04-15
NO20006455D0 (no) 2000-12-18
CN1305488A (zh) 2001-07-25
SK19402000A3 (sk) 2001-07-10
ZA200006813B (en) 2002-02-21
IL139689A0 (en) 2002-02-10
PT1087986E (pt) 2002-08-30
RU2216546C2 (ru) 2003-11-20
HK1034263A1 (en) 2001-10-19
HUP0102274A3 (en) 2002-08-28
US20050153949A1 (en) 2005-07-14
KR100596649B1 (ko) 2006-07-06
HUP0102274A2 (hu) 2001-12-28
TR200003743T2 (tr) 2001-07-23
US6989378B2 (en) 2006-01-24
CZ293319B6 (cs) 2004-04-14
EP1087986A1 (de) 2001-04-04
PL191285B1 (pl) 2006-04-28
ES2175989T3 (es) 2002-11-16
PL344987A1 (en) 2001-11-19
CN1172949C (zh) 2004-10-27
CZ20004779A3 (en) 2001-06-13
CA2333985C (en) 2007-04-10
DE69901250D1 (de) 2002-05-16
CA2333985A1 (en) 1999-12-29
IL139689A (en) 2004-09-27
US20040033999A1 (en) 2004-02-19
DK1087986T3 (da) 2002-06-17
JP2002518514A (ja) 2002-06-25
AU756739B2 (en) 2003-01-23
ID27260A (id) 2001-03-22
DE69901250T2 (de) 2002-10-17
NZ508299A (en) 2003-04-29
WO1999067271A1 (en) 1999-12-29
NO20006455L (no) 2000-12-18
BR9911344A (pt) 2001-03-13

Similar Documents

Publication Publication Date Title
AU756739B2 (en) Testosterone derivative
JP2702280B2 (ja) ヒト前立腺腺癌治療用医薬組成物
AU2001249661B2 (en) Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
AU2001249661A1 (en) Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
US10351587B2 (en) Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate
WO1999067270A1 (en) Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
MXPA00012805A (en) Testosterone derivative
EP1427748B1 (de) 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung
AU2002339536A1 (en) 17alpha-hydroxy-14beta-steroids with hormonal effect
AU2002258664A1 (en) Methods of making, using and pharmaceutical formulations comprising 7alpha, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17-esters thereof
WO2003045398A1 (en) Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090614